levonorgestrel has been researched along with Fibroid in 60 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.67) | 18.7374 |
| 1990's | 3 (5.00) | 18.2507 |
| 2000's | 22 (36.67) | 29.6817 |
| 2010's | 29 (48.33) | 24.3611 |
| 2020's | 5 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Baracat, EC; Ferreira-Filho, ES; Magalhaes, J; Soares-Junior, JM | 1 |
| La Marca, A; Selmi, C | 1 |
| Lumbiganon, P; Pattanittum, P; Sangkomkamhang, US | 1 |
| Boudova, B; Cindrova-Davies, T; Fanta, M; Kuzel, D; Lisa, Z; Mara, M; Zizka, Z | 1 |
| Goldstein, SR; Lumsden, MA | 1 |
| Laopaiboon, M; Lumbiganon, P; Mol, BW; Sangkomkamhang, US | 1 |
| Beltrame, A; Bernardes, CR; de Souza, IM; Machado, RB; Morimoto, MS; Santana, N | 1 |
| Dutta, S; Jana, N; Rakshit, BM; Roy, SB; Saha, PK; Sengupta, G | 1 |
| Cancelo Hidalgo, MJ | 1 |
| Munro, MG; Solnik, MJ | 1 |
| Bastianelli, C; Benagiano, G; Brosens, I; Farris, M | 1 |
| Chen, M; Jiang, W; Shen, Q; Wang, Y; Zhou, Q; Zhu, X | 1 |
| Granberg, S | 1 |
| Albano, A; De Trana, E; Di Cello, A; Gallo, F; La Ferrera, N; Morelli, M; Russo, V; Venturella, R; Zullo, F | 1 |
| Fu, Z; Ji, C; Ling, J; Wu, J; Wu, X; Xu, Q | 1 |
| Baktiroglu, M; Dogan, Y; Kahramanoglu, I; Karateke, A; Senol, T; Suer, N | 1 |
| Leake, R; Stewart, CJ | 1 |
| Abraham, T; Arian, SE; Bartels, CB; Cayton, KC; Chuong, FS; Holthouser, K; Segars, JH | 1 |
| Centini, G; Kashani, BN; Morelli, SS; Petraglia, F; Weiss, G | 1 |
| Curtis, KM; Phillips, SJ; Steyn, PS | 1 |
| Bahamondes, L; Bahamondes, MV; Monteiro, I | 1 |
| Caglar, GS; Cengiz, H; Gunes, M; Kayikcioglu, F; Tasci, Y; Yagci, B | 1 |
| Loisel, C; Marpeau, L; Puscasiu, L; Roman, H; Sentilhes, L | 1 |
| Cebi, M; Murat Naki, M; Ozcan, N; Tekcan, C | 1 |
| Maruo, T | 2 |
| Curtis, KM; Jamieson, DJ; Marchbanks, PA; Tepper, NK; Whiteman, MK; Zapata, LB | 1 |
| Luo, L; Qiu, L; Xu, C; Xu, Q; Zhu, L | 1 |
| Chen, W; Maruo, T; Nakabayashi, K; Ohara, N; Sasaki, H; Xu, Q; Yamada, H; Yoshida, S | 1 |
| El-Nashar, SA; Sayed, GH; Shaaban, MM; Zakherah, MS | 1 |
| Blidaru, I; Boiculese, L; Miron, N; Socolov, D; Socolov, R; Tamba, B | 1 |
| Agarwal, N; Awasthi, D; Kriplani, A; Kulshrestha, V | 1 |
| Gemzell-Danielsson, K; Heikinheimo, O | 1 |
| Bouchard, P | 1 |
| Manyonda, I; Talaulikar, VS | 1 |
| Chen, J; Wan, S; Xie, ZW; Xu, WZ; Zhang, YN | 1 |
| Ekholm, E; Grenman, S; Hurskainen, R; Inki, P; Kivelä, A; Kujansuu, E; Paavonen, J; Palo, P; Teperi, J; Yliskoski, M | 1 |
| Ikomi, A; Pepra, EF | 1 |
| Bifulco, G; Cerrota, G; De Simone, R; Di Spiezio Sardo, A; Mercorio, F; Nappi, C; Vanacore, F | 1 |
| Chen-Mok, M; Grigorieva, V; Mikhailov, A; Tarasova, M | 1 |
| Eizenberg, DH | 1 |
| Mercorio, F | 1 |
| Soysal, ME; Soysal, S | 1 |
| Hurskainen, R; Paavonen, J | 1 |
| Banu, NS; Manyonda, IT | 1 |
| McGavigan, CJ; Owen, P | 1 |
| Gupta, JK; Sinha, D; Varma, R | 1 |
| Aldrighi, JM; de Lima, GR; Magalhães, J | 1 |
| Kaunitz, AM | 1 |
| Chen, W; Johansson, ED; Maruo, T; Matsuo, H; Ohara, N; Sitruk-Ware, R; Xu, Q | 1 |
| Higgins, M; Kelehan, P; O'Herlihy, C; Rizkalla, HF | 1 |
| Coleman, M; Farquhar, C; McCowan, L | 1 |
| Abulafia, O; Sherer, DM | 1 |
| Fong, YF; Singh, K | 1 |
| Iwanicki, M; Starczewski, A | 1 |
| Schacht, E; Wildemeersch, D; Wildemeersch, P | 1 |
| Schacht, E; Wildemeersch, D | 1 |
| Tiltman, AJ | 1 |
26 review(s) available for levonorgestrel and Fibroid
| Article | Year |
|---|---|
Oral hormonal therapy as treatment option for abnormal uterine bleeding.
Topics: Contraceptives, Oral, Combined; Female; Humans; Leiomyoma; Levonorgestrel; Menorrhagia; Progestins; Quality of Life; Uterine Hemorrhage | 2023 |
Progestogens or progestogen-releasing intrauterine systems for uterine fibroids (other than preoperative medical therapy).
Topics: Adult; Antineoplastic Agents, Hormonal; Bias; Contraceptives, Oral; Desogestrel; Female; Goserelin; Humans; Intrauterine Devices, Medicated; Leiomyoma; Leuprolide; Levonorgestrel; Lynestrenol; Medroxyprogesterone Acetate; Menstruation; Middle Aged; Nandrolone; Norethindrone Acetate; Premenopause; Progestins; Randomized Controlled Trials as Topic; Tumor Burden; Uterine Neoplasms | 2020 |
Abnormal uterine bleeding in perimenopause.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Contraceptives, Oral, Combined; Diagnostic Imaging; Endometrial Hyperplasia; Endometrium; Female; Genital Neoplasms, Female; Humans; Hysteroscopy; Leiomyoma; Levonorgestrel; Middle Aged; Perimenopause; Pregnancy; Quality of Life; Uterine Hemorrhage | 2017 |
Progestogens or progestogen-releasing intrauterine systems for uterine fibroids.
Topics: Antineoplastic Agents, Hormonal; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Leuprolide; Levonorgestrel; Lynestrenol; Medroxyprogesterone Acetate; Menstruation; Premenopause; Progestins; Randomized Controlled Trials as Topic; Tumor Burden; Uterine Neoplasms | 2013 |
[Hormonal treatments for hemorrhaging secondary to fibroids. An alternative or complement to surgery?].
Topics: Combined Modality Therapy; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Estrogen Receptor Modulators; Estrogens; Female; Humans; Hysterectomy; Leiomyoma; Levonorgestrel; Norpregnenes; Progesterone; Progestins; Treatment Outcome; Uterine Hemorrhage; Uterine Neoplasms | 2013 |
Indications and alternatives to hysterectomy.
Topics: Adenomyosis; Aromatase Inhibitors; Chronic Pain; Endometrial Hyperplasia; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Hysterectomy; Hysteroscopy; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Pelvic Pain; Polyps; Uterine Artery Embolization; Uterine Diseases; Uterine Hemorrhage; Uterine Myomectomy; Uterine Neoplasms | 2014 |
Selective progesterone receptor modulators: an update.
Topics: Adenomyosis; Animals; Clinical Trials as Topic; Contraception, Postcoital; Contraceptive Agents, Female; Contraceptives, Postcoital; Endometriosis; Estrenes; Female; Hormone Antagonists; Humans; Leiomyoma; Levonorgestrel; Mifepristone; Norpregnadienes; Oximes; Receptors, Progesterone; Uterine Neoplasms | 2014 |
Levonorgestrel-releasing intrauterine system use in premenopausal women with symptomatic uterine leiomyoma: a systematic review.
Topics: Antineoplastic Agents, Hormonal; Drug Implants; Drug Screening Assays, Antitumor; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Premenopause; Uterine Neoplasms; Uterus | 2014 |
An Evidence-based Approach to the Medical Management of Fibroids: A Systematic Review.
Topics: Androgens; Aromatase Inhibitors; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Curcumin; Delayed-Action Preparations; Drugs, Chinese Herbal; Estradiol; Estrenes; Estrogen Receptor Antagonists; Evidence-Based Medicine; Female; Fulvestrant; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Medroxyprogesterone Acetate; Mifepristone; Neoadjuvant Therapy; Norpregnadienes; Oximes; Plant Extracts; Receptors, Progesterone; Selective Estrogen Receptor Modulators; Tea; Uterine Myomectomy; Uterine Neoplasms; Vitamin D; Vitamins | 2016 |
Role of Medical Management for Uterine Leiomyomas.
Topics: Antifibrinolytic Agents; Aromatase Inhibitors; Cabergoline; Cholecalciferol; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Danazol; Dopamine Agonists; Ergolines; Estrenes; Estrogen Antagonists; Female; Gestrinone; Gonadotropin-Releasing Hormone; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Mifepristone; Norpregnadienes; Oximes; Patient Care Planning; Selective Estrogen Receptor Modulators; Somatostatin; Tranexamic Acid; Uterine Neoplasms; Vitamins | 2016 |
The safety of Sino-implant (II) for women with medical conditions or other characteristics: a systematic review.
Topics: Bone Density; China; Contraception Behavior; Contraceptive Agents, Female; Drug Implants; Female; Humans; Leiomyoma; Levonorgestrel; Ovarian Cysts; Patient Satisfaction; Randomized Controlled Trials as Topic; Weight Gain | 2016 |
Levonorgestrel-releasing intrauterine system: uses and controversies.
Topics: Contraception; Contraceptive Agents, Female; Endometrial Hyperplasia; Endometriosis; Endometrium; Estrogen Replacement Therapy; Female; Genital Diseases, Female; HIV Infections; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Risk Assessment; Thrombophilia; Treatment Outcome; Uterine Neoplasms | 2008 |
Intrauterine device use among women with uterine fibroids: a systematic review.
Topics: Contraceptive Agents, Female; Female; Ferritins; Hematocrit; Hemoglobins; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Uterine Hemorrhage; Uterine Neoplasms | 2010 |
Translational research with progesterone receptor modulator motivated by the use of levonorgestrel-releasing intrauterine system.
Topics: Animals; Extracellular Matrix; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Neovascularization, Pathologic; Progesterone; Receptors, Progesterone; Translational Research, Biomedical; Uterine Neoplasms | 2010 |
Emerging indications for the levonorgestrel-releasing intrauterine system (LNG-IUS).
Topics: Contraceptive Agents, Female; Endometrial Hyperplasia; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Uterine Neoplasms | 2012 |
Current and future medical treatments for menometrorrhagia during the premenopause.
Topics: Adolescent; Adult; Contraceptives, Oral; Endometrial Neoplasms; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Levonorgestrel; Menorrhagia; Metrorrhagia; Mifepristone; Norpregnadienes; Polyps; Premenopause; Progestins; Randomized Controlled Trials as Topic; Receptors, Progesterone; Uterine Neoplasms | 2011 |
Progesterone and progesterone receptor modulators in the management of symptomatic uterine fibroids.
Topics: Endometrium; Estrenes; Female; Hormone Antagonists; Humans; Hyperplasia; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Mifepristone; Norpregnadienes; Oximes; Receptors, Progesterone | 2012 |
Efficacy of the levonorgestrel intrauterine system in treating menorrhagia: actualities and ambiguities.
Topics: Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Progesterone Congeners; Uterine Diseases; Uterine Neoplasms | 2002 |
Levonorgestrel-releasing intrauterine system in the treatment of heavy menstrual bleeding.
Topics: Contraceptive Agents, Female; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia | 2004 |
Alternative medical and surgical options to hysterectomy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Endometrium; Female; Humans; Hysterectomy; Leiomyoma; Levonorgestrel; Menorrhagia; Myometrium; Quality of Life; Uterine Diseases | 2005 |
The levonorgestrel-releasing intrauterine system in modern gynaecology.
Topics: Contraceptive Agents, Female; Endometriosis; Female; Hormone Replacement Therapy; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Premenstrual Syndrome; Uterine Hemorrhage; Uterine Neoplasms | 2005 |
Non-contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS)--a systematic enquiry and overview.
Topics: Delayed-Action Preparations; Dysmenorrhea; Endometrial Hyperplasia; Endometrial Neoplasms; Endometriosis; Estrogen Replacement Therapy; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia | 2006 |
Progestin-releasing intrauterine systems and leiomyoma.
Topics: Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Randomized Controlled Trials as Topic; Receptors, Progesterone; Uterine Neoplasms | 2007 |
Effects of levonorgestrel-releasing IUS and progesterone receptor modulator PRM CDB-2914 on uterine leiomyomas.
Topics: Contraceptive Agents, Female; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Norpregnadienes; Progesterone; Receptors, Progesterone; Uterine Neoplasms | 2007 |
The levonorgestrel-releasing intrauterine device: a wider role than contraception.
Topics: Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menstruation Disturbances; Uterine Neoplasms | 1997 |
Angiogenesis of the endometrium.
Topics: Carcinoma; Endometrial Hyperplasia; Endometrial Neoplasms; Endometriosis; Endometrium; Female; Humans; Leiomyoma; Levonorgestrel; Neovascularization, Physiologic | 1999 |
6 trial(s) available for levonorgestrel and Fibroid
| Article | Year |
|---|---|
Levonorgestrel-releasing intrauterine device use as an alternative to surgical therapy for uterine leiomyoma.
Topics: Adult; Amenorrhea; Female; Hemoglobins; Humans; Intrauterine Devices; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Middle Aged; Prospective Studies; Uterine Neoplasms | 2015 |
A randomized clinical trial of a levonorgestrel-releasing intrauterine system and a low-dose combined oral contraceptive for fibroid-related menorrhagia.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Female; Hemoglobins; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Treatment Failure; Treatment Outcome | 2011 |
Levonorgestrel releasing-intrauterine system for the treatment of menorrhagia and/or frequent irregular uterine bleeding associated with uterine leiomyoma.
Topics: Adult; Contraceptive Agents, Female; Device Removal; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Middle Aged; Organ Size; Patient Satisfaction; Severity of Illness Index; Treatment Outcome; Tumor Burden; Ultrasonography; Uterine Hemorrhage; Uterine Neoplasms; Uterus | 2011 |
Comparison of ovarian cyst formation in women using the levonorgestrel-releasing intrauterine system vs. hysterectomy.
Topics: Adult; Female; Humans; Hysterectomy; Leiomyoma; Levonorgestrel; Menorrhagia; Middle Aged; Ovarian Cysts; Ovary; Progesterone Congeners; Prospective Studies; Ultrasonography; Uterine Neoplasms; Uterus; Vagina | 2002 |
The efficacy of levonorgestrel-releasing intrauterine device in selected cases of myoma-related menorrhagia: a prospective controlled trial.
Topics: Adult; Female; Hemoglobins; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Prospective Studies; Treatment Outcome | 2005 |
Treatment of primary and secondary dysmenorrhea with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
Topics: Adolescent; Adult; Drug Delivery Systems; Dysmenorrhea; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Magnetic Resonance Imaging; Middle Aged; Pain; Pilot Projects; Progesterone Congeners; Ultrasonography | 2001 |
28 other study(ies) available for levonorgestrel and Fibroid
| Article | Year |
|---|---|
Uterine volume, menstrual patterns, and contraceptive outcomes in users of the levonorgestrel-releasing intrauterine system: A cohort study with a five-year follow-up.
Topics: Adenomyosis; Cohort Studies; Contraceptive Agents; Contraceptive Agents, Female; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Uterine Hemorrhage | 2022 |
Hysteroscopic management of endometrial polyps and submucous leiomyomas in women using a levonorgestrel-releasing intrauterine system.
Topics: Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Polyps; Uterine Hemorrhage; Uterine Neoplasms | 2022 |
Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin, Number 228.
Topics: Antifibrinolytic Agents; Contraceptive Agents, Hormonal; Endometrial Ablation Techniques; Ethinyl Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Hysterectomy; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Tranexamic Acid; Uterine Artery Embolization; Uterine Hemorrhage; Uterine Myomectomy; Uterine Neoplasms; Watchful Waiting | 2021 |
The levonorgestrel-releasing intrauterine system: its effect on the number of hysterectomies performed in perimenopausal women with uterine fibroids.
Topics: Adult; Female; Humans; Hysterectomy; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Longitudinal Studies; Middle Aged; Patient Satisfaction; Perimenopause; Prospective Studies; Uterine Hemorrhage; Uterine Neoplasms | 2013 |
Management of abnormal uterine bleeding in women with mechanical heart valve prosthesis and anticoagulant therapy.
Topics: Adult; Anticoagulants; Catheter Ablation; Contraceptive Agents, Female; Female; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Hysterectomy; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Middle Aged; Prospective Studies; Uterine Hemorrhage; Uterine Neoplasms | 2011 |
Are two intrauterine contraceptive devices better than one?
Topics: Contraceptive Agents, Female; Diagnostic Errors; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Middle Aged; Ultrasonography; Uterine Neoplasms; Uterus | 2014 |
[Use of progesterone-releasing intra-uterine system in menhorragia relapse prevention after laparoscopic myomectomy].
Topics: Adult; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Laparoscopy; Leiomyoma; Levonorgestrel; Menorrhagia; Pelvic Pain; Quality of Life; Retrospective Studies; Secondary Prevention; Time Factors; Uterine Myomectomy | 2014 |
Effects of miRNA-197 overexpression on proliferation, apoptosis and migration in levonorgestrel treated uterine leiomyoma cells.
Topics: Adult; Apoptosis; Cell Movement; Cell Proliferation; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Humans; Leiomyoma; Levonorgestrel; MicroRNAs; Middle Aged; Tumor Cells, Cultured; Uterine Neoplasms | 2015 |
Endometrial Synovial-like Metaplasia Associated With Levonorgestrel-releasing Intrauterine System.
Topics: Adult; Biomarkers; Contraceptive Agents, Female; Endometrial Hyperplasia; Endometrium; Female; Foreign-Body Reaction; Humans; Immunohistochemistry; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Metaplasia; Middle Aged; Synovial Membrane | 2015 |
Treatment of menorrhagia with the levonorgestrel releasing intrauterine system: effects on ovarian function and uterus.
Topics: Adult; Contraceptives, Oral, Synthetic; Estradiol; Female; Follicle Stimulating Hormone; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Luteinizing Hormone; Menorrhagia; Middle Aged; Ovary; Regression Analysis; Uterine Neoplasms; Uterus | 2009 |
[Management of menometrorrhagia in women with and without pregnancy intention: hierarchy of therapies].
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Contraceptives, Oral, Hormonal; Embolization, Therapeutic; Endometrial Hyperplasia; Estrogens; Female; Humans; Hysterectomy; Infertility, Female; Leiomyoma; Levonorgestrel; Metrorrhagia; Polyps; Pregnancy; Progestins; Tranexamic Acid; Uterine Neoplasms; Uterus | 2008 |
Levonorgestrel-releasing intrauterine device insertion ameliorates leiomyoma-dependent menorrhagia among women of reproductive age without a significant regression in the uterine and leiomyoma volumes.
Topics: Adult; Age Factors; Delayed-Action Preparations; Drug Delivery Systems; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Middle Aged; Treatment Outcome; Uterine Neoplasms; Uterus; Young Adult | 2010 |
ACOG Practice Bulletin No. 110: noncontraceptive uses of hormonal contraceptives.
Topics: Acne Vulgaris; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Dysmenorrhea; Endometriosis; Female; Genital Diseases, Female; Hirsutism; Humans; Leiomyoma; Levonorgestrel; Menstruation; Ovarian Cysts; Premenstrual Syndrome; Uterine Neoplasms | 2010 |
Translational research in women's health: from bedside to bench and from bench to bedside.
Topics: Apoptosis; Clinical Trials as Topic; Female; Humans; Intrauterine Devices; Leiomyoma; Levonorgestrel; Menorrhagia; Norpregnadienes; Proliferating Cell Nuclear Antigen; Receptors, Progesterone; Translational Research, Biomedical; Uterine Neoplasms; Women's Health | 2010 |
Levonorgestrel inhibits proliferation and induces apoptosis in uterine leiomyoma cells.
Topics: Adult; Apoptosis; Cell Proliferation; Contraceptive Agents, Female; Female; Formazans; Histocytochemistry; Humans; Inhibitor of Apoptosis Proteins; Insulin-Like Growth Factor I; Leiomyoma; Levonorgestrel; Microscopy, Electron, Transmission; Microtubule-Associated Proteins; Middle Aged; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Survivin; Tetrazolium Salts; Tumor Cells, Cultured; Uterine Neoplasms | 2010 |
Efficacy of the levonorgestrel-releasing intrauterine system in uterine leiomyoma.
Topics: Adult; Female; Humans; Hysterectomy; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Middle Aged; Prospective Studies; Treatment Outcome; Uterine Neoplasms | 2012 |
Levonorgestrel-releasing intrauterine device is an efficacious contraceptive for women with leiomyoma.
Topics: Adult; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Menstruation; Middle Aged; Uterine Neoplasms | 2012 |
The effect of a levonorgestrel-releasing intrauterine device in the treatment of myoma-related menorrhagia.
Topics: Adult; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Progesterone Congeners; Uterine Neoplasms | 2003 |
Use of a levonorgestrel-releasing intrauterine system to treat bleeding related to uterine leiomyomas.
Topics: Adult; Female; Hemoglobins; Humans; Leiomyoma; Levonorgestrel; Menstruation; Middle Aged; Prospective Studies; Uterine Hemorrhage; Uterine Neoplasms | 2003 |
Update on treatment of menstrual disorders.
Topics: Adult; Contraceptive Agents, Female; Cost-Benefit Analysis; Embolization, Therapeutic; Female; Humans; Hysterectomy, Vaginal; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Menstruation Disturbances; Middle Aged; Uterine Neoplasms | 2003 |
Differing results for efficacy--sampling bias or purposive sampling?
Topics: Contraceptive Agents, Female; Female; Humans; Intrauterine Devices; Leiomyoma; Levonorgestrel; Selection Bias; Treatment Outcome; Uterine Hemorrhage; Uterine Neoplasms | 2003 |
Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas.
Topics: Adult; Amenorrhea; Cohort Studies; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Menstruation; Middle Aged; Oligomenorrhea; Prospective Studies; Time Factors; Treatment Outcome; Uterine Neoplasms; Uterus | 2007 |
Progesterone and progesterone receptor modulator in uterine leiomyoma growth.
Topics: Contraceptive Agents, Female; Female; Humans; Intrauterine Devices; Leiomyoma; Levonorgestrel; Norpregnadienes; Receptors, Progesterone | 2007 |
Pathological findings associated with the presence of a mirena intrauterine system at hysterectomy.
Topics: Endometrial Hyperplasia; Endometriosis; Female; Humans; Hysterectomy; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Retrospective Studies; Treatment Failure; Uterine Neoplasms; Uterus | 2008 |
Effect of the levonorgestrel-releasing intrauterine system on uterine myomas in a renal transplant patient.
Topics: Adult; Blood Transfusion; Contraceptive Agents, Female; Dysmenorrhea; Female; Hematinics; Hemoglobins; Humans; Intrauterine Devices, Medicated; Kidney Transplantation; Leiomyoma; Levonorgestrel; Menorrhagia; Ovary; Ultrasonography; Uterine Neoplasms; Uterus | 1999 |
[Intrauterine therapy with levonorgestrel releasing IUD of women with hypermenorrhea secondary to uterine fibroids].
Topics: Adult; Contraceptives, Oral, Synthetic; Drug Administration Routes; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Uterine Neoplasms | 2000 |
The effect on menstrual blood loss in women with uterine fibroids of a novel "frameless" intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
Topics: Adult; Drug Delivery Systems; Drug Implants; Female; Humans; Leiomyoma; Levonorgestrel; Menorrhagia; Middle Aged; Pilot Projects; Ultrasonography; Uterine Neoplasms; Uterus | 2002 |
The effect of progestins on the mitotic activity of uterine fibromyomas.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Follow-Up Studies; Humans; Leiomyoma; Levonorgestrel; Medroxyprogesterone; Middle Aged; Mitosis; Norethindrone; Norgestrel; Uterine Neoplasms; Uterus | 1985 |